Table 2.
Bone ultrasound parameter, laboratory data, and vertebral fractures in HIV infection and control group; results are expressed as number, means ± S.D. and percentage.
| Parameter | HIV (n = 100) | Control Group (n = 100) |
|---|---|---|
| Vertebral fractures (VFs), n (%) | 16 (16) * | 2 (2) |
| Stiffness index (SI) (%) | 80.58 ± 19.95 § | 92.18 ± 8.06 |
| T-Score (D.S.) | −1.70 ± 0.50 § | -0.70 ± 0.30 |
| Z-Score (D.S.) | −1.20 ± 0.40 § | -0.10 ± 0.30 |
| Osteocalcin (pg/mL) | 21.31 ± 4.95 | 20.33 ± 4.35 |
| C-terminal telopeptide (ng/mL) | 0.53 ± 0.28 | 0.48 ± 0.35 |
| Parathyroid hormone level (pg/dL) | 43.72 ± 25.40 | 37.64 ± 23.60 |
| 25-hydroxivitamin D3 (ng/mL) | 20.29 ± 4.05 § | 35.77 ± 6.50 |
| Calcium (mg/dL) | 9.02 ± 0.47 | 9.12 ± 0.46 |
| Phophate (mg/dL) | 3.11 ± 0.57 | 3.14 ± 0.43 |
| Urinary calcium (mg/24 h) | 210.29 ± 84.05 | 213.93 ± 140.35 |
| Urinary phophate (mg/24 h) | 1010.29 ± 260.05 | 1063.53 ± 461.50 |
| Vitamin A (g/dL) | 62.65 ± 13.89 | 62.33 ± 13.22 |
| Creatinine (mg/dL) | 0.88 ± 0.07 | 0.89 ± 0.09 |
* p < 0.05; § p < 0.001.